| Platform |  | Pricing | Only free issues | Publishes | Daily |
|---|---|---|---|---|---|
| Issues | 647 | Founded | 5 years ago | Last Issue | 6 days ago |
| Active | |||||
Read this Newsletter
bioclandestine.substack.comLatest Issues
The Dems are Waging War Against the American People
Observe the timeline:
-Dems try to remove Trump via Mueller/Russia/Impeachment in his 1st term.
-Dems successfully remove Trump in 2020 via releasing a man-made biological weapon, fear campaign, mass uprisings/unrest, mass mail-in ballots...
Trump Openly Accuses Dems of Trying to Assassinate Him in Butler
Holy shit. Trump just openly accused the Dems of being involved in his assassination attempt in Butler, and covering up the evidence.
New info just came out that the shooter had weapon parts shipped to him under a fake name, and his body w...
Why We Must Win the AI Race
Our adversaries do NOT want to see the US win the AI race.
Why? Because if the US win the AI race, in combination with our unmatched military prowess and our vast resources/economic power, the US will become an impenetrable self-sustaining...
We’ve Been at War Since 9/11/2001
REMINDER: We have technically been at war since 9/11/2001.
On 9/18/2001, the Authorization for Use of Military Force was signed into law, against any and all who planned, authorized, committed, or aided, the 9/11 attacks,
The US MIL have...
The Left Murdered Charlie
It’s been one year since Charlie Kirk was assassinated by a brainwashed Left-winger, who was manipulated by an endless stream of violent anti-Trump and anti-American propaganda, spread by the MSM.
All the hysteria and madness surrounding C...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Clandestine’s Newsletter.
| Subscribers | Engagement | 91 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
SEO Reach
Where Clandestine’s Newsletter ranks on Google, and how much search traffic it brings in.
| Ranked Keywords | 2 | Monthly Search Traffic | Top Keywords |
|---|
Authors
The writers behind this newsletter.
Investigative Journalist and Bioethics Whistleblower
Frequently Asked Questions
How can I access the email archive for Clandestine’s Newsletter?
You can find recent issues that have been published by Clandestine’s Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Clandestine’s Newsletter have?
To see how many people subscribe to Clandestine’s Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Clandestine’s Newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Clandestine’s Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Clandestine’s Newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Clandestine’s Newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Clandestine’s Newsletter?
Scroll up to where it says Related Newsletters to see other publications like Clandestine’s Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Clandestine’s Newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.